Serum total cholesterol as a biomarker for Alzheimer’s disease: Mid-life or late-life determinations?

2006 ◽  
Vol 41 (9) ◽  
pp. 805-806 ◽  
Author(s):  
Francesco Panza ◽  
Cristiano Capurso ◽  
Alessia D’Introno ◽  
Anna M. Colacicco ◽  
Federico Vasquez ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Total Cholesterol ◽  
Late Life ◽  
Serum Total Cholesterol

Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

1998 ◽  
Vol 17 (1) ◽  
pp. 14-20 ◽  
Author(s):  
Irma-Leena Notkola ◽  
Raimo Sulkava ◽  
Juha Pekkanen ◽  
Timo Erkinjuntti ◽  
Christian Ehnholm ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Apolipoprotein E ◽  
Total Cholesterol ◽  
Serum Total Cholesterol ◽  
E4 Allele

scholarly journals When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression

2018 ◽  
Vol 10 ◽  
Author(s):  
Claudio Liguori ◽  
Mariangela Pierantozzi ◽  
Agostino Chiaravalloti ◽  
Giulia M. Sancesario ◽  
Nicola B. Mercuri ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Decline ◽  
Late Life ◽  
The Elderly ◽  
Csf Biomarkers ◽  
Late Life Depression

Cognitive impairment in remitted late-life depression is not associated with Alzheimer's disease-related CSF biomarkers

2020 ◽  
Vol 272 ◽  
pp. 409-416
Author(s):  
Júlia C. Loureiro ◽  
Florindo Stella ◽  
Marcos V. Pais ◽  
Marcia Radanovic ◽  
Paulo R. Canineu ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Late Life ◽  
Csf Biomarkers ◽  
Late Life Depression
Sign in / Sign up

Export Citation Format

Share Document